Print

Please select the PCN:

Opioids Prescribing: Balancing Measures

 

Indicator O5

Anxiolytics and Hypnotics - Average Daily Quantity per item by all CCGs (i-chart)

Sorry, chart data coming soon

 

More information about this indicator

Description: Number of average daily quantities (ADQs) per item for anxiolytics and hypnotics

Why it matters: Anxiolytics and Hypnotics are drugs that are prescribed for short-term treatment of conditions such as anxiety and sleep problems.

This measure shows the mean Average Daily Quantity (ADQ) given per prescription, for both the older benzodiazepines, such as diazepam and temazepam, and the newer "Z-drugs", such as zopiclone.

It excludes items that do not have an ADQ, such as melatonin.

Please follow this link for a detailed technical specification

Data for this indicator has been sourced from openprescribing.net

 

 

Indicator O6

Prescribing of gabapentin and pregabalin (DDD) by all CCGs (i-chart)

Sorry, chart data coming soon

 

More information about this indicator

Description: Total DDD of pregabalin + gabapentin per 1000 patients

Why it matters: Gabapentin and pregabalin are increasingly used in neuropathic and other types of pain, and use is rising rapidly in the NHS.

Defined Daily Dose (DDD): The assumed average maintenance dose per day for a drug used for its main indication in adults

Please follow this link for a detailed technical specification

Data for this indicator has been sourced from openprescribing.net

 

Indicator O7

Prescribing of pregabalin by all CCGs (i-chart)

Sorry, chart data coming soon

 

More information about this indicator

Description: Prescribing of pregabalin per 1000 patients

Why it matters: Pregabalin is a relatively new drug, which is increasingly used in neuropathic and other types of pain. Also its costs have reduced recently, its use is rising increasingly rapidly in the NHS. There are also concerns about the potential for abuse.

Please follow this link for a detailed technical specification

Data for this indicator has been sourced from openprescribing.net

NB: Low volume figures have not been redacted and therefore individual patients may be identifiable. Please take care when disseminating data and contact your Caldicott Guardian for further guidance.

Hits: 335